{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:04:35Z","timestamp":1767625475113,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:00:00Z","timestamp":1659830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:00:00Z","timestamp":1659830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-022-01939-3","type":"journal-article","created":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T14:02:16Z","timestamp":1659880936000},"page":"1453-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-2110","authenticated-orcid":false,"given":"Peter","family":"Bramlage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-6135","authenticated-orcid":false,"given":"Sascha R.","family":"Tittel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"M\u00fcther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Reinhart-Steininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Haberland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semik","family":"Khodaverdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Zimny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Ohlenschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3789-6459","authenticated-orcid":false,"given":"Stefanie","family":"Lanzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Haak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,7]]},"reference":[{"issue":"23","key":"1939_CR1","first-page":"1913","volume":"171","author":"CH Bergholtz","year":"2009","unstructured":"Bergholtz CH, Olsen B, Johannesen J (2009) Insulin pump therapy in children and teenagers. Ugeskr Laeger 171(23):1913\u20131918","journal-title":"Ugeskr Laeger"},{"issue":"1","key":"1939_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/dmrr.2653","volume":"32","author":"P Pozzilli","year":"2016","unstructured":"Pozzilli P et al (2016) Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev 32(1):21\u201339","journal-title":"Diabetes Metab Res Rev"},{"key":"1939_CR3","first-page":"CD005103","volume":"1","author":"ML Misso","year":"2010","unstructured":"Misso ML et al (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 1:CD005103","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"1939_CR4","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMct1113948","volume":"366","author":"JC Pickup","year":"2012","unstructured":"Pickup JC (2012) Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 366(17):1616\u20131624","journal-title":"N Engl J Med"},{"issue":"3","key":"1939_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4158\/EP11265.RA","volume":"18","author":"K Kaiserman","year":"2012","unstructured":"Kaiserman K et al (2012) Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus. Endocr Pract 18(3):418\u2013424","journal-title":"Endocr Pract"},{"issue":"2","key":"1939_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2337\/dc07-1378","volume":"31","author":"SA Weinzimer","year":"2008","unstructured":"Weinzimer SA et al (2008) A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Diabetes Care 31(2):210\u2013215","journal-title":"Diabetes Care"},{"key":"1939_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.diabres.2016.03.008","volume":"115","author":"B Bohn","year":"2016","unstructured":"Bohn B et al (2016) Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: analysis of real-life data from the DPV registry from Germany and Austria. Diabetes Res Clin Pract 115:31\u201338","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1939_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jpeds.2015.09.006","volume":"167","author":"KO Schwab","year":"2015","unstructured":"Schwab KO et al (2015) Non-high-density lipoprotein cholesterol in children with diabetes: proposed treatment recommendations based on glycemic control, body mass index, age, sex, and generally accepted cut points. J Pediatr 167(6):1436\u20131439","journal-title":"J Pediatr"},{"issue":"12","key":"1939_CR9","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1093\/clinchem\/33.12.2267","volume":"33","author":"DCCT Research Group","year":"1987","unstructured":"DCCT Research Group (1987) Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group. Clin Chem 33(12):2267\u20132271","journal-title":"Clin Chem"},{"issue":"4","key":"1939_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2337\/diacare.13.4.427","volume":"13","author":"DCCT Research Group","year":"1990","unstructured":"DCCT Research Group (1990) Diabetes control and complications trial (DCCT). Update DCCT Research Group. Diabetes Care 13(4):427\u2013433","journal-title":"Diabetes Care"},{"issue":"5","key":"1939_CR11","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/diacare.28.5.1245","volume":"28","author":"Workgroup on Hypoglycemia, A.D.A","year":"2005","unstructured":"Workgroup on Hypoglycemia, A.D.A (2005) Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28(5):1245\u20131249","journal-title":"Diabetes Care"},{"issue":"10","key":"1939_CR12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00592-020-01538-0","volume":"57","author":"SR Tittel","year":"2020","unstructured":"Tittel SR et al (2020) Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes. Acta Diabetol 57(10):1245\u20131253","journal-title":"Acta Diabetol"},{"key":"1939_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/1753-0407.13215","volume":"13","author":"SR Tittel","year":"2021","unstructured":"Tittel SR et al (2021) Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types: a prospective, matched control study. J Diabetes 13:1007\u20131014","journal-title":"J Diabetes"},{"issue":"6","key":"1939_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-2006-944549","volume":"38","author":"RP Hoogma","year":"2006","unstructured":"Hoogma RP, Schumicki D (2006) Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes. Horm Metab Res 38(6):429\u2013433","journal-title":"Horm Metab Res"},{"issue":"6","key":"1939_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/dia.2010.0224","volume":"13","author":"AC van Bon","year":"2011","unstructured":"van Bon AC et al (2011) Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial. Diabetes Technol Ther 13(6):607\u2013614","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"1939_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/diacare.25.3.439","volume":"25","author":"B Bode","year":"2002","unstructured":"Bode B et al (2002) Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes. Diabetes Care 25(3):439\u2013444","journal-title":"Diabetes Care"},{"issue":"6","key":"1939_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/dia.2008.0013","volume":"10","author":"PD Bartolo","year":"2008","unstructured":"Bartolo PD et al (2008) Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes. Diabetes Technol Ther 10(6):495\u2013498","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"1939_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3810\/pgm.2002.05.1200","volume":"111","author":"BW Bode","year":"2002","unstructured":"Bode BW, Tamborlane WV, Davidson PC (2002) Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med 111(5):69\u201377 (quiz 27)","journal-title":"Postgrad Med"},{"issue":"2","key":"1939_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F et al (2020) 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41(2):255\u2013323","journal-title":"Eur Heart J"},{"issue":"3","key":"1939_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s13300-018-0411-7","volume":"9","author":"K Norgaard","year":"2018","unstructured":"Norgaard K et al (2018) Efficacy and safety of rapid-acting insulin analogs in special populations with type 1 diabetes or gestational diabetes: systematic review and meta-analysis. Diabetes Ther 9(3):891\u2013917","journal-title":"Diabetes Ther"},{"key":"1939_CR21","unstructured":"Institute for Quality and Efficiency in Health Care (2009) Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1-follow-up commission: executive summary of final report A08\u201301, version 1.0. 2005\u20132009. Cologne, Germany"},{"key":"1939_CR22","unstructured":"UK National Institute for Health and Care Excellence (2015) Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]. 29.01.2020. www.nice.org.uk\/guidance\/ng18"},{"issue":"2","key":"1939_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13300-019-00743-7","volume":"11","author":"A Janez","year":"2020","unstructured":"Janez A et al (2020) Insulin therapy in adults with type 1 diabetes mellitus: a narrative review. Diabetes Ther 11(2):387\u2013409","journal-title":"Diabetes Ther"},{"issue":"11","key":"1939_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-2005-870584","volume":"37","author":"M Dreyer","year":"2005","unstructured":"Dreyer M et al (2005) Efficacy and safety of insulin glulisine in patients with type 1 diabetes. Horm Metab Res 37(11):702\u2013707","journal-title":"Horm Metab Res"},{"issue":"11","key":"1939_CR25","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.2337\/diacare.25.11.2053","volume":"25","author":"J Plank","year":"2002","unstructured":"Plank J et al (2002) A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes. Diabetes Care 25(11):2053\u20132057","journal-title":"Diabetes Care"},{"issue":"2","key":"1939_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4158\/EP10260.RA","volume":"17","author":"BW Bode","year":"2011","unstructured":"Bode BW (2011) Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Endocr Pract 17(2):271\u2013280","journal-title":"Endocr Pract"},{"issue":"1","key":"1939_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12916-017-0958-6","volume":"15","author":"MAM Rogers","year":"2017","unstructured":"Rogers MAM et al (2017) Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. BMC Med 15(1):199","journal-title":"BMC Med"},{"issue":"2","key":"1939_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2337\/dc09-1503","volume":"33","author":"S Ehehalt","year":"2010","unstructured":"Ehehalt S et al (2010) Epidemiological perspectives on type 1 diabetes in childhood and adolescence in germany: 20 years of the Baden-wurttemberg Diabetes Incidence Registry (DIARY). Diabetes Care 33(2):338\u2013340","journal-title":"Diabetes Care"},{"issue":"6","key":"1939_CR29","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1177\/193229681300700620","volume":"7","author":"D Kerr","year":"2013","unstructured":"Kerr D et al (2013) Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review. J Diabetes Sci Technol 7(6):1595\u20131606","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"1939_CR30","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/jps.24039","volume":"103","author":"BM Teska","year":"2014","unstructured":"Teska BM et al (2014) Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature. J Pharm Sci 103(8):2255\u20132267","journal-title":"J Pharm Sci"},{"issue":"2","key":"1939_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.xphs.2015.10.023","volume":"105","author":"C Zhou","year":"2016","unstructured":"Zhou C et al (2016) Characterization of sizes of aggregates of insulin analogs and the conformations of the constituent protein molecules: a concomitant dynamic light scattering and Raman spectroscopy study. J Pharm Sci 105(2):551\u2013558","journal-title":"J Pharm Sci"},{"issue":"11","key":"1939_CR32","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s11095-017-2233-0","volume":"34","author":"K Gast","year":"2017","unstructured":"Gast K et al (2017) Rapid-acting and human insulins: hexamer dissociation kinetics upon dilution of the pharmaceutical formulation. Pharm Res 34(11):2270\u20132286","journal-title":"Pharm Res"},{"key":"1939_CR33","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/pedi.13094","volume":"21","author":"O Kordonouri","year":"2020","unstructured":"Kordonouri O et al (2020) Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine? Pediatr Diabetes 21:1285\u20131291","journal-title":"Pediatr Diabetes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-022-01939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-022-01939-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-022-01939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T15:10:21Z","timestamp":1664377821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-022-01939-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,7]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["1939"],"URL":"https:\/\/doi.org\/10.1007\/s00592-022-01939-3","relation":{},"ISSN":["1432-5233"],"issn-type":[{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2022,8,7]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PB reports to have received consultancy honoraria from Sanofi and Abbott. TH reports to have received consultancy honoraria from Novo Nordisk, Lilly, Sanofi, MSD, Abbott, Boehringer Ingelheim, Dexcom, and Bayer. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The DPV initiative, which was established in 1995, was approved by the ethics committee of the University of Ulm, and data collection was approved by local review boards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants before enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}